In a different study, higher levels of the serum neuronal injury marker Ubiquitin carboxy-terminal hydrolase L1 (UCHL1), but not GFAP, were linked to neurological manifestations in COVID-19 patients at ICU admission [79]. This evidence concerns the gene GFAP and COVID-19.